Literature DB >> 12894266

Clinical and cerebrospinal fluid (CSF) profile and CSF criteria for the diagnosis of spinal cord schistosomiasis.

Otávio Augusto Moreno-Carvalho1, Cristiana Maria Nascimento-Carvalho, Aroldo Luiz da Silva Bacelar, Antônio de Souza Andrade-Filho, Gersonita Costa, Jandira Bastos Fontes, Telma Assis.   

Abstract

OBJECTIVES: To describe the clinical and CSF findings among patients with presumptive neuroschistosomiasis (NS) and to suggest a classification for the CSF diagnosis of presumptive NS.
METHOD: The charts of all patients whose CSF exam was performed at the CSF Lab, Jos Silveira Foundation, Salvador, Brazil, from 1988 to 2002 were reviewed. Those with clinically suspected NS whose indirect fluorescent antibody test (IFA) and or hemagglutination-inhibiting antibodies test (HAI) were positive to S. mansoni were identified.
RESULTS: Of 377 patients, 67.9% were males; the median age was 36 years (mean 37 + 16 yrs, range 3-82 yrs). The most frequent complaints were paraparesis (59.9%), urinary retention (36.2%), lower limb pain (22.8%). WBC of CSF (count/mm ) was > 4 in 66.0% (mean 83 + 124, median 40, range 4.3-1,100), protein (mg/dl) was > 40 in 84.6% (mean 185 + 519, median 81, range 41-6,800) and eosinophils were present in 46.9%. IFA and HAI were positive in 75.3%. WBC > 4 and presence of eosinophils were associated with IFA and HAI positive (67.3% versus 51.4%, p 0.014; 49.1% versus 23.0%, p 0.0001, respectively) and protein > 40 was not (85.4% versus 77.0%, p 0.09). Presence of WBC > 4, protein > 40 and eosinophils was associated with IFA and HAI positive (71.6% versus 38.2%, p 0.0003) but presence of eosinophils and any other combination of WBC and protein were not.
CONCLUSION: NS should be considered as a possible diagnosis in patients who had had contact with schistosome-infected water and present with spinal cord compromising. Presence of IFA and HAI positive to S. mansoni, WBC > 4, protein > 40 and presence of eosinophils in the CSF may be considered as a criterium of highly probable presumptive diagnosis.

Entities:  

Mesh:

Year:  2003        PMID: 12894266     DOI: 10.1590/s0004-282x2003000300006

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  7 in total

1.  Brain magnetic resonance imaging findings in young patients with hepatosplenic schistosomiasis mansoni without overt symptoms.

Authors:  Adonis Manzella; Paulo Borba-Filho; Carlos T Brandt; Keyla Oliveira
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

2.  Myeloradiculopathy associated to Schistosoma mansoni.

Authors:  Patrícia Pita Lobo; Miguel Coelho; Ruth Geraldes; Carolina Santos; Maria Grácio; Mário Miguel Rosa; João Lobo Antunes
Journal:  BMJ Case Rep       Date:  2011-08-11

3.  Cerebral neuroschistosomiasis: a rare clinical presentation and review of the literature.

Authors:  Jara Llenas-García; Juan-Manuel Guerra-Vales; Andrea Alcalá-Galiano; Cristina Domínguez; Angel Pérez-Nuñez; Manuel Lizasoaín; Carmen Díaz-Pedroche; Santiago Montes; Josefina Martínez; Fernando Sierra; Efren Salto
Journal:  BMJ Case Rep       Date:  2009-08-19

Review 4.  Update on eosinophilic meningoencephalitis and its clinical relevance.

Authors:  Carlos Graeff-Teixeira; Ana Cristina Arámburu da Silva; Kentaro Yoshimura
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

Review 5.  Medullary neuroschistosomiasis in adolescence: case report and literature review.

Authors:  Patricia Alessandra Dastoli; Adriana Lima Leite; Marcos Devanir Silva da Costa; Jardel Mendonça Nicácio; Ricardo Silva Pinho; Maria Aparecida Gadiani Ferrarini; Sergio Cavalheiro
Journal:  Childs Nerv Syst       Date:  2021-06-24       Impact factor: 1.475

6.  Schistosomal myeloradiculopathy due to Schistosoma mansoni: Report on 17 cases from an endemic area.

Authors:  Hatem I Badr; Ashraf A Shaker; Mohamed A Mansour; Mohamed A Kasem; Ahmad A Zaher; Hassan H Salama; Mohamed I Safwat
Journal:  Ann Indian Acad Neurol       Date:  2011-04       Impact factor: 1.383

7.  Central nervous system infections in travelers.

Authors:  H L Kirsch; K T Thakur; G L Birbeck
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.663

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.